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ABSTRACT
A novel protein family, designated hereafter as
RNase i (kappa) family, has been recently intro-
duced with the characterization of the specific Cc
RNase, isolated from the insect Ceratitis capitata.
The human ortholog of this family consists of 98
amino acids and shares >98% identity with its
mammalian counterparts. This RNase is encoded
by a single-copy gene found to be expressed in a
wide spectrum of normal and cancer tissues. The
cDNA of the human ribonuclease has been isolated
and subcloned into a variety of prokaryotic expres-
sion vectors, but most efforts to express it caused a
severe toxic effect. On the other hand, the expres-
sion of the human RNase by the use of the
methylotrophic yeast Pichia pastoris system
resulted in the production of a highly active
recombinant enzyme. Using a 30-mer 5’-end-labeled
RNA probe as substrate, the purified enzyme
seems to preferentially cleave ApU and ApG phos-
phodiester bonds, while it hydrolyzes UpU bonds at
a lower rate. Based on amino acid sequence
alignment and substrate specificity data, as well
as the complete resistance of the recombinant
protein to the placental ribonuclease inhibitor,
we concluded that the human RNase i is a
novel endoribonuclease distinct from other known
ribonucleases.
INTRODUCTION
RNA molecules are endowed with a very special role in
the mechanism of gene expression and therefore in cell
diﬀerentiation. A very wide spectrum of enzymes known
as RNases catalyzes the degradation of polymeric RNA
and participates in a wide range of biological events in
both the intracellular and extracellular level (1,2). In
recent years a focused study on RNases has led to the
identiﬁcation of novel ribonucleolytic enzymes in both
prokaryotic and eukaryotic cells, even though their
biological role in most cases remains undeﬁned (2).
The RNase A superfamily has been a subject of intense
biochemical study for many decades. Dozens of novel
members of the RNase A superfamily have been identiﬁed
in multiple vertebrate species and their biochemical
properties as well as their biological roles have been
intensively studied (3–14). Among the interesting features
of this superfamily is its dynamic evolutionary history,
which involved a series of gene duplications and advanta-
geous amino acid substitutions.
Human RNases have been the epicenter of the interest
in RNases for a long time. So far eight members of the
RNase A superfamily have been studied in humans and
despite the fact that they have been fully characterized in
the biochemical level their in vivo activity remains obscure
(13). On the other hand human exoribonucleases have
been studied less extensively, but have been shown to
exhibit key roles in the processing and maturation of
human RNA molecules. The members of the RNase A
superfamily share a relatively high level of homology
and their genes are located on human chromosome 14.
In addition to their catalytic activity, members of this
superfamily have been shown to possess important
biological actions other than a simple digestive role.
As examples, human RNase 5 (angiogenin) promotes
blood vessel formation, while human RNase 2 (eosino-
phil-derived neurotoxin, EDN) and human RNase 3
(eosinophil cationic protein, ECP) exert neurotoxic,
immunosuppressive and antiviral activities (15–17). In a
recent publication, ﬁve new members of the RNase A
superfamily have been identiﬁed by in silico analysis in
humans, even though some of them seem to lack the
catalytic amino acids and therefore do not bear ribonu-
cleolytic activity (18).
In this work, we present the molecular cloning and
characterization of a novel human endoribonuclease,
designated as human RNase k, which belongs to a
recently identiﬁed protein family. The ﬁrst member of
this family that has been studied is Cc RNase, isolated
from the insect Ceratitis capitata (19). Cc RNase is a
small, thermolabile ribonuclease consisting of 95 amino
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human ortholog was expressed in bacteria and yeast and
its study revealed that the recombinant protein displays
ribonucleolytic activity, as also was observed in the case of
Cc RNase.
MATERIALS AND METHODS
Materials
Oligonucleotide synthesis and sequence analysis were
performed by MWG Biotech (Ebersberg, Germany).
Restriction enzymes, T4 DNA ligase and T4 polynucleo-
tide kinase were purchased from New England Biolabs.
Plasmid preparation kits and Protino His-Bind resin were
from Macherey-Nagel. All bacterial expression vectors
and bacterial strains, the anti-His tag monoclonal anti-
bodies and the horseradish peroxidase conjugated goat
anti-mouse IgG were purchased from Novagen. rRNA
was extracted from rat liver polysomes as described
previously by Rampias et al. (19). KM71 Pichia pastoris
host cells and the yeast expression vector pPICZaA were
purchased from Invitrogen. Multiple Tissue Northern
Blot membrane was purchased from Clontech (#7760-1).
Torula yeast RNA, the synthetic substrates poly (C) and
poly (U) and the alkaline phosphatase conjugated goat
anti-chicken IgG were obtained from Sigma (St Louis,
MO/USA). Marker proteins for molecular weight estima-
tions in SDS–PAGE were obtained from Fermentas. All
other reagents used were of analytical grade and obtained
from Merck.
Production of aspecific polyclonal antibodyagainst
human RNase i
The synthetic peptide AVLIEDVPFTEKDFE, corre-
sponding to human RNase k deduced amino acid
sequence residues 38–52, was used for the preparation of
the custom anti-human RNase k speciﬁc polyclonal
antibody. Peptide synthesis and antibody production
was performed by Sigma-Genosys. Brieﬂy, the synthesized
peptide was puriﬁed by HPLC, conjugated to KLH and
the conjugated synthetic peptide was used for the
immunization of Rhode Island Red Chickens over a
10-week immunization protocol.
Isolationof thecDNA clone encoding human RNase i
One microgram of poly(A)
+ RNA from human placenta
was reverse transcribed using the SMART PCR cDNA
synthesis kit (Clontech Laboratories) as speciﬁed in the
manufacturer’s manual. In order to clone the human
RNase k cDNA, a PCR reaction was performed using the
FH (50- GCT TGC ACC TCG GCG AT-30) and RH
(50-GAA GGG ATT CAG TCT CTC GC-30) primers,
which anneal at the 50 and 30 sequences of the untranslated
regions of the human RNase k mRNA, respectively. The
PCR product was cloned into the pCR
TM 2.1 cloning
vector (Invitrogen) and sequenced in both directions.
Construction of theexpression plasmids
Ampliﬁcation of the open reading frame (ORF) of the
human RNase k was carried out using the proofreading
Fast Start Taq DNA polymerase (Roche) and primers
speciﬁc to the 50 (starting at the ATG initiator codon) and
30 ends of the human RNase k cDNA based on nucleotide
sequence (Accession No AM746459). The primers used
were designed so that the ampliﬁed DNA would contain
EcoRI and XbaI restriction endonuclease sites at its 50
and 30 ends, respectively, in order to facilitate subsequent
subcloning. The primer sequences were as follows: sense,
50-GAA TTC ATG GCG TCG CTC CTG TGC-30;
antisense, 50-TCT AGA GCG CGC ACC ATG TAT
TCC TTG-30. The ampliﬁed cDNA fragment was ﬁrst
cloned into pCR
TM 2.1 vector and the EcoRI–XbaI DNA
fragment was puriﬁed and subcloned into the pPICZa A
P. pastoris expression vector, creating the paA construct.
Using slightly modiﬁed sense and antisense primers
containing diﬀerent restriction sites, the human RNase k
cDNA was cloned into the prokaryotic expression vectors
pET 15b (XhoI–BamHI insert), pET 20b (NcoI–XhoI
insert), pET 29b (NspV–XhoI insert), pET 39b (NspV–
XhoI insert), pET coco-1 (NheI–HindIII insert) and
pSCREEN-1b(+) (NspV–XhoI insert). All constructs
were conﬁrmed by DNA sequencing.
Transformation of P. pastoris andselection of
RNase-producing clones
Transformation of P. pastoris KM71 host cells was
performed by electroporation as described by the manu-
facturer’s manual. Brieﬂy, SacI linearized paA construct
was electroporated with KM71 cells in a 0.2ml sterile
electroporation cuvette at 1.5kV (Gene pulser, Bio-Rad).
Cells were then plated onto yeast extract peptone dextrose
sorbitol (YPDS; 1% yeast extract, 2% peptone, 2%
glucose, 1M sorbitol) agar plates containing 100, 200 and
500g/ml Zeocin (Invitrogen), respectively and incubated
at 308C for 2–3 days until single colonies were formed.
Screening for gene replacement of the construct by
homologous recombination at the AOX1 locus, was
conﬁrmed by PCR analysis of chromosomal DNA using
the 50 AOX1 and 30 AOX1 universal primers as described
in the manufacturer’s manual.
For the detection of the RNase-producing strains, a
number of recombinant colonies was inoculated in 10ml-
buﬀered complex glycerol medium (BMGY; 1% yeast
extract, 2% peptone, 100mM potassium phosphate, pH
6.0, 1.34% YNB, 4 10
–5% biotin, 1% glycerol) and
incubated at 308C in a shaking incubator (250r.p.m.). The
cultures were centrifuged and the cells were re-suspended
in appropriate volume of buﬀered complex methanol
medium (BMMY; 1% yeast extract, 2% peptone, 100mM
potassium phosphate, pH 6.0, 1.34% YNB, 4 10
–5%
biotin, 0.5% methanol) so that OD600 was 2. The cultures
were maintained for 4 days and supplemented daily with
0.5% v/v methanol. One milliliter of each culture was
harvested every day; the supernatants were clariﬁed by
centrifugation (10min, 10000g,4 8C) and stored at  808C
until tested. The presence of recombinant RNase in the
supernatants was detected by Dot Blot analysis using the
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ability to cleave rRNA.
Large-scale production of recombinant human RNase k
was performed under similar conditions using the colony
that rendered the best yield in the small-scale experiments.
Production and purification of recombinant human
RNase i inyeast
One hundred milliliters of extracellular medium obtained
2 days after the induction were concentrated about 20
times by ultraﬁltration in a diaﬂow pressure cell with an
YM-10 membrane. The concentrated material was diluted
1:4 with IBW buﬀer consisting of 50mM sodium
phosphate–NaOH pH 8.0, 300mM NaCl and loaded
onto a 1ml Protino His-bind Resin column (Macherey-
Nagel). After washing with the equilibration IBW buﬀer,
the recombinant protein was eluted with IBW buﬀer
containing 250mM imidazole. The fractions containing
the puriﬁed human RNase k were pooled and the puriﬁed
protein was dialyzed overnight against 20mM Tris–HCl
pH 8.0.
Protein purity was assessed by SDS–PAGE according
to Laemmli (20). Polyacrylamide gels were either stained
with Coomassie blue or electroblotted onto a nitrocellu-
lose membrane as described by Towbin et al. (21). The
recombinant protein was immunodetected using either an
anti-His tag monoclonal antibody (1000-fold dilution) or
a polyclonal antibody raised in chicken against a speciﬁc
oligopeptide of the human RNase k. Protein concentra-
tion was determined using a Bio-Rad (Richmond, CA,
USA) protein assay kit based on the Bradford dye-binding
assay (22). Calibration curves were constructed using
bovine serum albumin as standard. Protein identiﬁcation
employing analysis of peptides resulting from the enzy-
matic digestion of the human RNase k by LC-ESI-MS
and MALDI-MS was performed by the Mass
Spectrometry Lab of the Institute of Biochemistry and
Biophysics of the Polish Academy of Sciences.
Expression ofthe human RNase iin bacteria
Overnight cultures of several types of Escherichia coli
host cells [Tunner(DE3), BL21(DE3), BL21(DE3)plysS,
Rosetta(DE3), Rosetta(DE3)plysS] harboring the recom-
binant expression vectors mentioned above, were diluted
1:50 in LB or M9 medium supplemented with the
appropriate antibiotics in each case. The eﬀect of the
recombinant protein expression on cell growth was
investigated as described by Rosenberg (23). The puriﬁca-
tion of the recombinant human RNase k, which had been
expressed in BL21(DE3)plysS cells transformed with the
recombinant pSCREEN-1b(+) vector, was achieved
following the puriﬁcation protocol employed in the case
of Cc RNase (19).
Assay forRNase activity
RNase activity of the recombinant protein against torula
yeast RNA (Sigma) or various single-stranded polyribo-
nucleotides was determined by the production of per-
chloric acid-soluble material according to the method of
Slifman et al. (24), with slight modiﬁcations. The reaction
was performed at 378C in a total volume of 50ml,
containing 50mg of the various substrates, in 20mM
Tris–HCl pH 8.0 and the appropriate amount of
recombinant protein. The reaction was stopped by
addition of 0.2ml ice-cold 7% perchloric acid containing
0.1% uranyl acetate and acid-soluble ribonucleotides
remaining in the supernatant fraction after centrifugation
were quantitated spectrophotometrically at 260nm. The
amount of enzyme used in the assays was selected such
that the rate of hydrolysis would be linear in the time
range examined.
Activity-staining gels
Recombinant human RNase k activity towards poly (U)
was also assayed by activity staining gel (25). The puriﬁed
protein was diluted in sample buﬀer devoid of any
reducing agent and analyzed in a 15% SDS polyacryla-
mide gel, containing 0.25mg/ml poly (U) as substrate.
Following electrophoresis, SDS was removed from the gel
by washing (2 10min) with 10mM Tris–HCl buﬀer
(pH 7.6) containing 2-propanol (20% v/v). Proteins were
renatured by washing the gel twice with 10mM Tris–HCl
buﬀer (pH 7.6). The gel was then incubated in a buﬀer of
0.1M Tris–HCl pH 7.6 for 3h, to allow the degradation of
the substrate to take place. The gel was stained with
10mM Tris–HCl buﬀer (pH 7.6) containing toluidine blue
(0.2% w/v) and distained with 10mM Tris–HCl buﬀer
(pH 7.6). Toluidine blue stains high-Mr nucleic acids
leaving regions in the gel that contain ribonucleolytic
activity appear as a clear band in a blue background.
Basespecificity ofthe human RNase i
The speciﬁc cleavage sites of the human RNase k were
determined by incubation of the ribonuclease with a
50-[g-
32P] ATP-labeled synthetic 30-mer oligoribonucleo-
tide of known sequence 50-CCCCGAUUUUAGCU
AUCUGGGUUCAACUUG-30. Human RNase k reac-
tions were performed in mixtures containing 20mM
Tris–HCl pH 8.0. The 1nt ladder was prepared by
alkaline hydrolysis of the 30-mer 50-end-labeled substrate
in a buﬀer containing 0.5mM EDTA, 75mM sodium
carbonate buﬀer (pH 9.2) at 908C for 20min. RNase T1
digestions were conducted by incubating the 30-mer
50-end-labeled probe in 15mM sodium citrate buﬀer
(pH 5.0), 1mM EDTA and 3.5M Urea with 1U of
RNase T1 (Sigma) at 558C for 15min. All reactions were
stopped with an equal volume of loading buﬀer containing
5mM Tris, 5mM boric acid, 0.05% bromophenol blue
and 10M Urea. The reaction products were analyzed on
17% denaturing polyacrylamide gel containing 8M Urea
and visualized by autoradiography.
Northern blotting analysis
The mRNA transcripts coding for the human RNase k
from various human tissues and organs were determined
by northern blot analysis. Human MTN Blot hybridiza-
tion membrane, containing 2mg poly(A)
+ RNA from
eight diﬀerent human tissues (heart, brain, placenta,
lung, liver, skeletal muscle, kidney and pancreas), was
used. Hybridization of the
32P-labelled cDNA probe
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k cDNA sequence was performed at 688C overnight in
25ml ExpressHybTM Hybridization Solution (Clontech).
Following hybridization the membrane was rinsed several
times in 2 SSC, 0.05% SDS at room temperature, twice
for 20min in 0.5 SSC, 0.1% SDS at 508C and twice
for 10min in 0.1 SSC, 0.1% SDS at 508C. The blot was
then covered immediately with plastic wrap, mounted on
Whatman paper and exposed to X-ray ﬁlm (Fuji ﬁlm) at
–808C with two intensifying screens.
Identification of RNase ifamily members
The dbEST (Expessed Sequence Tags) (26) database on
the National Center for Biotechnology Information
World Wide Web server was searched by the TBLASTN
software (27). Multiple sequence alignment was performed
by the Clustal W 1.8 program (28) using default
parameters.
RESULTS
Identification and isolation ofthe human RNase icDNA
In previous work conducted in our laboratory, we
presented the isolation and characterization of a novel
ribonuclease, designated as Cc RNase, which bears high
similarity with a group of sequences of unknown function,
expanding from Caenorhabditis elegans to humans (19).
A TBLASTN search of the available human EST
sequence databases, using the deduced amino acid
sequence of the homologous Cc RNase as query, resulted
in the retrieval of a large number of EST sequences
distributed in a variety of tissues. Based on the alignment
of these sequences a set of speciﬁc oligonucleotide primers
(FH and RH) was designed. In order to isolate the human
RNase k cDNA, 1mg of poly(A)
+ RNA from human
placenta was reverse transcribed and the retrieved single-
strand cDNA molecules were ampliﬁed by PCR using the
FH and RH primers. The puriﬁed ampliﬁcation product
was cloned into the PCR
TM 2.1 vector and ﬁve cDNA
clones were selected and subjected to sequence analysis.
Sequencing results (EMBL database, Accession
No. AM746459) revealed no diﬀerences among these
clones, which additionally appear to be identical with
three of the previously submitted in the UniGene NCBI
database (Hs.632232) mRNA sequences (Acc No.
BC051802.1, Acc No. NM001004333.2 and Acc No.
BC062705.1). The isolated cDNA clone has a length of
466bp and includes an ORF of 297nt encoding a protein
of 98 amino acids with a calculated molecular mass of
10984kDa.
The gene encoding the human RNase k (MGC71993)
is located on chromosome 17, map position 17p13.1,
corresponding to the LOC440400 gene locus. Genomic
DNA and cDNA sequencing comparisons revealed that
the human RNase k gene consists of three exons
interrupted by two introns with a length of 904 and
402bp, respectively. The ﬁrst exon (118bp) includes 40bp
of the 50 untranslated region and encodes the ﬁrst 26
amino acids of the human protein. The second exon has a
length of 77bp, which code for the next 26 amino acids,
and the third one consists of 387bp, 139bp of which
encode the last 46 amino acids, while the rest 245
nucleotides belong to the 30 untranslated region.
Conservation of theRNase ifamily
Using the default settings of NCBI and the deduced amino
acid sequence of the human RNase k as query, a
TBLASTN search of the available EST sequence data-
bases was conducted. This search resulted in the retrieval
of a large number of EST sequences bearing high
similarity to human RNase k, which expand throughout
the animal kingdom. Multiple alignments of the deduced
amino acid sequences belonging to diﬀerent mammalian
representatives indicated that the human RNase k is an
extremely conserved protein. It displays 100% identity
compared to the predicted homologous proteins of
monkeys, mice, rats and sheep, while cattle and pig
proteins bear only one and two amino acid substitutions,
respectively (Figure 1).
Expression analysis of thehuman RNase imRNA
The TBLASTN search of the available human EST
sequence databases resulted in the retrieval of a large
number of EST clones (412 up today) prepared from a
variety of normal (placenta, brain, kidney, etc.) and cancer
tissues (osteosarcoma, breast adenocarcinoma, insuli-
noma, retinoblastoma, etc.). In order to conﬁrm the
organ distribution of the human RNase k, a human
multiple tissue northern blot membrane was hybridized
using the 466bp human RNase k cDNA probe, as
described in the Materials and Methods section. As
shown in Figure 2, northern hybridization displayed the
existence of a main mRNA transcript with an estimated
length of 700nt expressed in all tissues examined. This
length is in agreement with that of the submitted
BC051802.1, NM001004333.2 and BC062705.1 mRNA
sequences mentioned above. It is interesting to point out
that two additional less abundant mRNA transcripts of
3.1 and 5kb, respectively, were identiﬁed only in brain,
placenta and pancreas.
H.sapiens       MASLLCCGPKLAACGIVLSAWGVIMLIMLGIFFNVHSAVLIEDVPFTEKDFE 52 
C.capitata      .K---I.....SL..LII.V..I.Q.VLM.L..YIN.VA....L.ID.-E.- 47
R.norvegicus    .................................................... 52
O.aries         .................................................... 52
M.musculus      .................................................... 52
M.mulatta       .................................................... 52
B.taurus        .................................................... 52
S.scrofa        .................................................... 52
H.sapiens       NGPQNIYNL----YEQVSYNCFIAAGLYLLLGGFSFCQVRLNKRKEYMVR 98 
C.capitata      .SVEEF.TAATCA.N.NA...W...CI.V.TLLL.AQ.FYV.S.AT--AN 95 
R.norvegicus    .........----..................................... 98 
O.aries         .........----..................................... 98 
M.musculus      .........----..................................... 98 
M.mulatta       .........----..................................... 98 
B.taurus        .........----............S........................ 98 
S.scrofa        ....D..K.----..................................... 98 
Figure 1. Amino acid alignment of the human RNase k and Cc RNase
with the predicted amino acid sequences retrieved from ESTs belonging
to other mammals. M. mulatta (Rhesus monkey): CB549243;
M. musculus (mouse): BC021603; R. norvegicus (rat): BP467900;
O. aries (sheep): EE797850; B. taurus (cattle): EH376754; S. scrofa
(pig): DB782459) and C. capitata AJ441124. Identical amino acids are
presented as dots and gaps as dashes.
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normal and cancer human tissues the vast majority of the
ESTs (almost 75%) is represented in cancer tissues and
only 25% in normal tissues. The wide expression of
human RNase k in multiple human adult tissues as well as
in fetal, juvenile tissues and carcinomas suggests a basic
housekeeping cellular function for this protein.
Expression ofthe human RNase iin E. coli
The coding region of the human RNase k cDNA was
cloned into a variety of prokaryotic expression vectors
including pET 15b, pET 20b, pET 29b, pET 39b, pET
coco-1 and pSCREEN-1b(+). Most of our eﬀorts to
express the human enzyme using these vectors and a wide
variety of E. coli host cells [Tunner(DE3), BL21(DE3),
BL21(DE3)plysS, Rosetta(DE3), Rosetta(DE3)plysS]
resulted either in lack of transformants or in severe toxic
eﬀects following IPTG induction. The inhibitory eﬀect
was not eliminated even when host cells harboring the
plysS plasmid, which produces lysozyme as an additional
means of reducing the recombinant protein expression
level, were used.
An alternative expression system, in which T7 RNA
polymerase is provided by infection with the bacterioph-
age CE6 (29) and is widely used for the expression of
extremely toxic genes, was also tested. Despite the fact
that this system has previously been successfully used for
the expression of the toxic ribonuclease RegB (30), eﬀorts
to express the human RNase k resulted again in severe cell
death.
Successful expression was achieved only after transfor-
mation of the recombinant pSCREEN-1b(+) vector into
BL21(DE3)plysS host cells. In this construct the target
protein is expressed as a fusion protein containing the ﬁrst
260 amino acids of the bacteriophage T7 gene 10 major
capsid protein at its N-terminus. Although the use of this
expression system resulted in the production of large
amounts of insoluble fusion protein, the mature puriﬁed
recombinant protein exhibited very low ribonucleolytic
activity against synthetic homopolyribonucleotides (data
not shown).
Expression of thehuman RNase iinP. pastoris
In order to overcome the problems related to the
expression of the human RNase k in prokaryotic systems,
the methylotrophic yeast P. pastoris expression system was
employed. The human RNase k cDNA was subcloned
into pPICZa A expression vector, creating the paA
construct. In this construct the target protein is expressed
as a small fusion protein containing a c-myc and a His-tag
epitope at its C-terminus. Furthermore, a signal peptide
facilitates the secretion of the produced recombinant
protein in the culture medium. The obtained transfor-
mants were selected on the basis of high antibiotic
resistance and the integration of the human RNase k
cDNA into the genomic yeast DNA was conﬁrmed by
PCR using the 50 AOX1 and 30 AOX1 universal primers.
The expression of the recombinant protein was veriﬁed by
western blot analysis using the monoclonal anti His-tag
antibody. As shown in Figure 3A, only one band with an
approximate molecular mass of 19kDa was detected 48h
after methanol induction in the culture medium, while no
signal was observed in a parallel control experiment. The
cultures’ supernatants were also tested for ribonucleolytic
activity against rRNA. As shown in Figure 3B, the
appearance of ribonucleolytic activity in the cultures’
supernatants follows the expression and secretion of the
recombinant protein.
Purification and characterization of theexpressed human
RNase i
The human RNase k secreted in the culture medium was
puriﬁed under native conditions using the Protino
His-Bind Resin as described in Materials and Methods
section. The puriﬁed protein appeared as a single band
and exhibited a molecular mass of  19kDa as estimated
by SDS–PAGE (Figure 4, lane 1). The identity of the
puriﬁed protein was immunologically veriﬁed using the
polyclonal antibody raised in chicken against a speciﬁc
oligopeptide of the human RNase k, as described in the
Materials and Methods section. Using this antibody
a single band migrating at the same position on the
SDS–PAGE was detected (Figure 4, lane 2). No
immunodetection was obtained when the same sample
was treated only with the second antibody (Figure 4, lane
3). When the ribonucleolytic activity of the puriﬁed
fraction was checked by SDS–PAGE in the presence of
poly (U), a single band corresponding to the molecular
mass of the puriﬁed protein was detected in the gel
followed by zymography (Figure 4, lane 4). In order to
prove that this band could not be attributed to
contaminating ribonucleolytic activity, it is signiﬁcant
1  2  3 4 5 6 7  8 
5 kb
3.1 kb
0.7 kb
Figure 2. Tissue distribution of the human RNase k mRNA.
PolyA+RNA (2mg) on a human multiple tissue blot (Clontech)
were hybridized to a
32P-labeled cDNA probe corresponding to
nucleotides 1–466 of the human RNase k cDNA sequence. 1: heart,
2: brain, 3: placenta, 4: lung, 5: liver, 6: skeletal muscle, 7: kidney, 8:
pancreas.
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when the puriﬁed recombinant protein was preincubated
at 998C for 5min, conditions which inactivate the human
RNase k (Figure 4, lane 5).
It is also important to note that the calculated mass
deduced from the amino acid sequence of the human
RNase k expressed by the paA construct in P. pastoris
(13937kDa) is deviated from that estimated by SDS–
PAGE. Therefore, in order to conﬁrm further the
identiﬁcation of the puriﬁed recombinant protein, the
pure elution fragment was analyzed on SDS–PAGE and
the 19kDa band was excised, digested with trypsin and the
resulted peptides were extracted and subjected to LC-ESI-
MS and MALDI-MS analysis. Data obtained from this
procedure resulted in the identiﬁcation of a number of
distinct peptide fragments covering 80% of the human
RNase k amino acid sequence.
The substrate speciﬁcity of the recombinant human
RNase k against poly (U), poly (C) and torula RNA was
determined by evaluating the generation of acid-soluble
ribonucleotides, as described in Materials and Methods
section. The recombinant enzyme degrades preferentially
poly (U), while it degrades torula yeast RNA at a lower
rate. No degradation of poly (C) was detected under
the same experimental conditions, although some minor
degradation of this substrate was observed after extended
incubation times and increased enzyme concentrations.
The human RNase k base speciﬁcity was determined
by incubation of the puriﬁed recombinant protein with
a5 0-
32P-labeled synthetic 30-mer RNA with known
sequence, followed by denaturing gel electrophoresis
-72 kDa
-55 kDa
-40 kDa
-33 kDa
-24 kDa 
-17 kDa 
-11 kDa 
28S 
18S 
Days Days
A B 
a  b 
0  1 2 3 4 0  1 2 3 4 0    1  2  3  4
Figure 3. Detection of the recombinant protein secreted in P. pastoris culture supernatant by immunoblotting analysis (A) and ribonucleolytic
activity (B). (A) Equal aliquots of the culture supernatant collected at 0, 1, 2, 3 and 4 days after methanol induction were analyzed by SDS–PAGE,
electro-transferred onto a nitrocellulose membrane and the expressed recombinant protein was detected using a monoclonal antibody against the His-
tag epitope and a goat anti-mouse IgG antibody conjugated to horseradish peroxidase (a). In a parallel experiment using only the second antibody
no bands were detected (b). (B) An aliquot of 2mg of rRNA isolated from rat liver was incubated at 378C for 30min with 5ml of supernatant from
the Pichia pastoris cultures collected at 0, 1, 2, 3 and 4 days after induction. The reaction products were analyzed by 1% agarose gel electrophoresis
and visualized with ethidium bromide staining. Arrows indicate 28S and 18S rat rRNA.
72 kDa -
55 kDa -
40 kDa -
33 kDa -
24 kDa -
17 kDa -
11 kDa -
M12345
Figure 4. SDS–PAGE, immunoblot analysis and activity staining of
the puriﬁed recombinant human RNase k. An aliquot of 2mgo f
the puriﬁed human RNase k was analyzed by SDS–PAGE and stained
with Coomassie blue (lane 1). A set of marker proteins of known
molecular weight (72, 55, 40, 33, 24, 17 and 11kDa top to bottom)
were run in parallel (lane M). Aliquots of the same amount of the
puriﬁed recombinant protein were analyzed by SDS–PAGE, electro
transferred onto a nitrocellulose membrane and detected using a
polyclonal antibody raised against a speciﬁc chemically synthesized
amino acid sequence of the human RNase k and a goat anti-chicken
antibody conjugated to alkaline phosphatase (lane 2). In a parallel
experiment using only the second antibody no band was detected (lane
3). An aliquot of 2mg of the puriﬁed recombinant protein (lane 4) and
an equivalent amount of this protein preincubated at 998C for 5min
(lane 5) were analyzed on a 15% polyacrylamide gel containing
0.25mg/ml poly (U). After electrophoresis the gel was stained for
RNase activity as described in Materials and Methods section.
6394 Nucleic Acids Research, 2007, Vol. 35, No. 19and autoradiography. As shown in Figure 5, lanes 4–7, the
ApU phosphodiester bond is mainly cleaved at the lowest
enzyme concentration, while increase of the enzyme
concentration enhances the cleavage of the ApG and
UpU phosphodiester bonds. The cleavage eﬃciency of the
preferred phosphodiester bonds is in correlation with
increasing incubation time (Figure 5, lanes 8–13).
The biochemical properties of the studied human
RNase k were tested using the 30-mer 50-end-labeled
RNA probe as substrate. The enzyme is active in a wide
pH range from 5 to 8 (Figure 5, lanes 14–18). The
sequence base speciﬁcity of this RNase is not aﬀected by
the presence of EDTA up to 20mM (Figure 5, lane 22) or
NaCl up to 250mM (Figure 5, lanes 23–25). Addition of
the alkylating agent NEM or iodoacetamide does not
inhibit the RNase activity of the recombinant enzyme in
concentrations up to 50mM (Figure 5, lanes 30 and 31).
The puriﬁed enzyme seems to remain unaﬀected in the
presence of Mg
+2 and Mn
+2, while 2mM Cu
+2 or Zn
+2
cause slight and total inhibition of its ribonucleolytic
activity, respectively (Figure 5, lanes 26–29). Addition of
the reducing agent DTT in concentrations >5mM causes
its complete inactivation leading to the conclusion that the
formation of disulﬁde bonds is essential for the retention
of enzymatic activity. On the other hand, the presence of
the placental ribonuclease inhibitor has no eﬀect on the
activity of the human RNase k, even at very high amounts
(40U) and limiting enzyme concentration (Figure 5, lanes
32–35). This ﬁnding adds an additional argument to the
fact that the RNase k family diﬀers signiﬁcantly from
the well-characterized RNase A superfamily. The eﬀect of
temperature on ribonucleolytic activity was determined
after preincubation of the recombinant enzyme at 37, 60
and 908C for various time periods (data not shown).
This experiment proved that the human RNase k is a
thermolabile molecule, since it loses most of its activity
after preincubation at 608C for 10min.
DISCUSSION
Ribonucleases can be considered as more than simple
RNA digesting enzymes. They act as messenger molecules
by interacting with actin, heparin and proteoglycans and
inﬂuence a wide range of functions. Their degrading
action on mRNA molecules has been under scrutiny for
a number of years, as this procedure seems to play an
important role in gene expression or translational control
and therefore in cell diﬀerentiation. Besides their digestive
role many RNases exhibit anti-tumor and cytotoxic
activity, while others exert aspermatogenic, anti-
embryonic, anti-bacterial, anti-viral or immunosuppres-
sive actions. In our previous work, we presented a novel
RNase, Cc RNase, isolated from the insect Ceratitis
capitata, which belongs to a novel highly conserved
protein family (19).
In this work, we report the isolation and characteriza-
tion of a cDNA clone encoding the human counterpart of
the RNase k (kappa) family along with the expression and
biochemical characterization of the recombinant enzyme.
Search of EST sequences databases, belonging to a variety
of diﬀerent organisms, proved that the RNase k family is
represented by a single ortholog in metazoans expanding
from C. elegans to humans, while no representatives have
been detected so far in yeast, plants and bacteria. All
members of this family are small proteins with polypeptide
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Figure 5. Base speciﬁcity and enzymatic characterization of human
RNase k. A 30-mer 50-labeled oligoribonucleotide of known sequence
was incubated without RNase k (lanes 1 and 19), in alkaline hydrolysis
buﬀer (lane 2) or with 1U of ribonuclease T1 (lanes 3 and 20). The
same amount of substrate was incubated at 378C with diﬀerent
amounts of puriﬁed recombinant protein (20, 50, 100, 200ng) for
30min (lanes 4–7, respectively) or with 30ng of puriﬁed recombinant
protein for 10, 20, 30, 40, 50 and 60min (lanes 8–13, respectively). For
the determination of the optimum pH of the human RNase k, the
50end-labeled probe was incubated with 25ng of recombinant protein in
50mM acetate buﬀer pH 5.0 and 6.0 (lanes 14 and 15) or 50mM
Tris–HCl pH 7.0, 8.0 and 9.0 (lanes 16–18). For the enzymatic
characterization of the human RNase k, the 5’end labelled probe was
incubated with 25ng of recombinant protein (except indicated
otherwise) in 20mM Tris–HCl pH 8.0at 378C for 30min (lane 21);
or in the presence of 5mM EDTA (lane 22); 100, 150 and 250mM
NaCl (lanes 23–25); 2mM Cu
+2,M g
+2,Z n
+2 and Mn
+2 (lanes 26–29,
respectively); 50mM NEM or iodoacetamide (lanes 30 and 31,
respectively). Lanes 32–35: 10ng human RNase k with 0, 10, 20 and
40U human placental inhibitor (RNasin). The partially digested RNA
probe was separated by 8M urea–17% polyacrylamide gel electrophor-
esis and visualized by autoradiography.
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signiﬁcant similarity to other known ribonucleases. It is
important to note that all members of this family seem to
be highly conserved with a conservation rate that in
mammals reaches a percentage >98%. This extremely
high conservation can be compared only to the increased
conservation rates exhibited by members of other protein
families with very signiﬁcant biological roles, such as the
histones (31) or phosphofructokinase (32).
As far as the genomic organization of the human RNase
k is concerned, the human RNase k gene is represented by
a single copy in the human genome and retains the pattern
of gene organization that is preserved by all known
members of the gene family, consisting of three exons
interrupted by two introns.
Northern blot analysis resulted in the detection of a
main mRNA of the human RNase k exhibiting a length of
700kb in all tissues examined. Two longer transcripts
of 3.1 and 5kb were found only in brain, placenta
and pancreas, while a third one with a length of 1.6kb
expressed in B cells (Ramos cell line) has already been
submitted in the databank (Acc No. CR607998.1).
Analysis of the retrieved EST sequences revealed that
the human RNase k mRNA is expressed in almost every
human tissue and developmental stage. This ﬁnding
suggests a basic housekeeping cellular function for this
protein. Concerning the breakdown of EST sequences of
the human RNase k by health state,  75% of them are
represented in cancer tissues while the rest in normal
tissues.
In most cases, the expression of the human RNase k in
bacteria caused a severe toxic eﬀect, resulting either in the
production of no transformants or in the inhibition of cell
growth and death of the transformed E. coli cultures
following IPTG induction. It is already known that the
expression of many human recombinant RNases with
important biological actions, such as ECP (23) or human
RNase 7 (33) produces similar toxic eﬀects. The toxic
eﬀect produced by the expression of the human RNase k
was not eliminated even when host cells, which produce
lysozyme as an additional means of reducing basal
expression of the recombinant protein or the expression
system of the bacteriophage CE6 were used. It is therefore
possible that the production of even a small amount of the
recombinant protein is suﬃcient to cause a severe toxic
eﬀect in E. coli. The successful expression of the human
RNase k in bacteria was achieved only after the
recombinant molecule was expressed as a fusion protein.
While this expression system produced a large amount of
insoluble fusion protein, an extremely low amount of
soluble human RNase k, which exhibited very little
ribonucleolytic activity, yielded after puriﬁcation.
Therefore, in order to express the human RNase k, the
methylotrophic yeast P. pastoris expression system, which
has been previously used successfully for the expression
of other toxic ribonucleases, such as the a-sarcin (34) or
onconase (35), was employed. Using this system, the
production of a highly active recombinant ribonucleolytic
enzyme was accomplished. Even though the calculated
molecular weight of the secreted recombinant protein is
almost 14kDa, the puriﬁed protein displays a molecular
mass of 19kDa as estimated by SDS–PAGE. Despite this
deviation the identity of the recombinant protein is
unquestionable, since the 19kDa protein exhibits ribonu-
cleolytic activity, immunoreacts with the polyclonal anti-
body raised against a speciﬁc oligopeptide of the human
RNase k as well as with the monoclonal anti-His tag
antibody and yields the expected peptide mapping proﬁle
as resulted by ESI-MS and MALDI-MS analysis. Since
the results obtained from the peptide analysis did not
report identiﬁcation of modiﬁed amino acids, the observed
diﬀerence among the theoretical and experimental mole-
cular weights could probably be attributed to an abnormal
electrophoretic mobility of the recombinant protein, as
has been previously reported in the case of the recombi-
nant ribonuclease U2 (36).
As far as the catalytic mechanism employed by the
human RNase k in the degradation of RNA is concerned,
the existence of one histidine residue (His36) in its amino
acid sequence raises a signiﬁcant point as to whether this
residue can take part in the catalytic mechanism. Two
histidine residues participate in acid–base catalysis caused
by all members of the RNase A superfamily (13), whereas
one histidine and one acidic amino acid are necessary for
the degradation of RNA from the fungal RNase T1 (37).
On the other hand, there are also ribonucleases such as
RNase III and RNase H type II, by which RNA catalysis
is carried out by acidic amino acid residues only (38–39).
Although experimental data concerning the catalytic
mechanism of the human RNase k have not been obtained
so far, residues Lys10, Asp43, Tyr62, Tyr76, Gln86 and
Asn90 of the human enzyme are found to be conserved in
all family members studied, therefore indicating a possible
participation in catalysis or in RNA base-speciﬁc
recognition.
The human RNase k contains ﬁve cysteine residues,
three of which Cys7, Cys14 and Cys69 are conserved
among all species examined. The ﬁnding that the
recombinant enzyme loses its activity by the addition of
DTT in the reaction mixture, while it remains fully active
in the presence of N-ethylmaleimide or iodoacetamide
leads us to the conclusion that cysteine residues are not
necessary for RNA catalysis, but stabilize the protein by
the formation of at least one disulﬁde bond.
Base speciﬁcity experiments indicated that the human
RNase k is probably a single-strand-speciﬁc endoribonu-
clease that preferentially cleaves ApU and ApG phospho-
diester bonds, while it hydrolyzes UpU bonds at a lower
rate. This novel RNase has no obvious relationship with
the pancreatic RNase family enzymes and seems more
similar to other human RNases, like RNase T84 (40),
RNase L (41) or RNase 4 (42). However, these enzymes
recognize diﬀerent dinucleotides than the human
RNase k. For example, RNase T84 catalyzes the hydro-
lysis of ApU and GpU phosphodiester bonds, RNase L
catalyzes the cleavage of UpU, UpA, UpG, ApA and
ApU, while RNase 4 hydrolyzes the phosphodiester bonds
of UpA and UpG.
Human RNase k sequence speciﬁcity also diﬀers from
the speciﬁcity for G and A nucleotides known for fungal
RNases, RNase T1 (43) and RNase U2 (44), respectively.
Furthermore, it seems to diﬀer from the fungal RNase Phy
6396 Nucleic Acids Research, 2007, Vol. 35, No. 19M (45), which cleaves RNA after U and A nucleotides.
The latter enzymes recognize all guanosine, adenine or
uracil nucleotides in the single-stranded RNA regions and
do not require a following nucleotide.
A comparison of the human RNase k with its
previously characterized C. capitata counterpart has
displayed a number of signiﬁcant similarities between
them. The human protein is three amino acids longer
consisting of 98 amino acids and displays 40% identity in
the amino acid level with Cc RNase. Most of our eﬀorts to
express these proteins in prokaryotic systems resulted
either in lack of transformants or severe cell death
following IPTG induction, thus indicating that the
production of either of these RNases is toxic to E. coli.
In both cases successful expression was achieved only by
the use of the pSCREEN 1b(+) vector, by which the
target RNases are expressed as fusion proteins. Even
though the use of this system produced satisfactory
amounts of recombinant fusion proteins, ribonucleolyti-
cally active mature protein yielded only in the case of Cc
RNase. The biochemical characterization of the human
and insect protein family representatives has proved that
both enzymes hydrolyze native and synthetic RNAs at the
same pH range, are thermolabile and are inhibited by
Zn
+2. Reduction of their disulﬁde bonds results in their
complete inactivation indicating that the formation of at
least one disulﬁde bond is essential for their catalytic
activity. Concerning the nucleotide base speciﬁcity both
enzymes cleave UpU phosphodiester bonds, while Cc
RNase cleaves CpC bonds more eﬀectively compared to
its human counterpart. Even though the ribonucleolytic
activity of Cc RNase has been characterized only by the
use of homopolymers, the ﬁnding that the human RNase
k displays a deviated speciﬁcity is not unusual since similar
data have been also reported in the case of other RNase
families. For example, frog ribonucleases of the RNase A
superfamily display a preference for the hydrolysis of
pyrimidine-G phosphodiester bonds compared to the
preference for pyrimidine-A phosphodiester bonds
displayed by their mammalian counterparts (46).
Furthermore, it is known that the speciﬁcity of dinucleo-
tide cleavage by angiogenins diﬀers among distinct family
members (47). Additionally, the RNase T1 variant RV,
bearing only ﬁve amino acid substitutions, exhibits a
stronger preference toward adenosine residues than wild-
type RNase T1 (48).
In summary, the characterization of the human RNase
k as the second member of a novel RNase family
establishes the identiﬁcation of the RNase k family in
metazoans. The nucleotide base speciﬁcity of the recom-
binant human representative, its lack of any signiﬁcant
homology to the members of the RNase A family and the
fact that the human counterpart evades the placental
ribonuclease inhibitor prove that there is no evolutionary
relationship between RNase A and k families. The high
conservation of all members of this RNase family in
combination with the fact that the human enzyme is found
to be expressed in all developmental stages and tissues
suggest a very important biological function, which
remains to be elucidated. Additionally, since it is well
known that a number of human RNases are involved with
pathogenic conditions, like autoimmune diseases, inﬂam-
matory disorders (49) or inhibition of tumor growth and
metastasis (50), a possible participation of the human
RNase k in the occurrence of such pathological situations
would be intriguing to be explored.
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